Xiaoyun Huang

Dongguan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Identification and validation of PANoptosis-related genes in Alzheimer's disease.

Identification and validation of PANoptosis-related genes in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 27, 2025

Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical Trial.

Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: November 03, 2025

The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis.

The LRRK2 P1446L mutation triggers dopaminergic neurodegeneration via DAPK1-mediated microglial neuroinflammation and neuronal apoptosis.

Journal: NPJ Parkinson's disease

Published: August 26, 2025

Eight-Year Longitudinal Study on the Assay Stability of Plasma Amyloid Beta 1-42 Peptide and Total Tau Protein Using Immunomagnetic Reduction.

Eight-Year Longitudinal Study on the Assay Stability of Plasma Amyloid Beta 1-42 Peptide and Total Tau Protein Using Immunomagnetic Reduction.

Journal: Molecular neurobiology

Published: February 08, 2025

HDL-Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS.

HDL-Apolipoprotein in Alzheimer's Disease Revisited: From Periphery to CNS.

Journal: Aging medicine (Milton (N.S.W))

Published: October 06, 2024

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.

Journal: Translational neurodegeneration

Published: July 26, 2024

A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson's disease.

A skin-specific α-Synuclein seeding amplification assay for diagnosing Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: March 21, 2024

Optimal Preservation of PFFs in Glycerol Enhances Suitability for Modeling Parkinson's Disease.

Optimal Preservation of PFFs in Glycerol Enhances Suitability for Modeling Parkinson's Disease.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: February 27, 2024

Identification of novel NLRP3 inhibitors as therapeutic options for epilepsy by machine learning-based virtual screening, molecular docking and biomolecular simulation studies.

Identification of novel NLRP3 inhibitors as therapeutic options for epilepsy by machine learning-based virtual screening, molecular docking and biomolecular simulation studies.

Journal: Heliyon

Published: August 06, 2023

Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.

Truncated DNM1 variant underlines developmental delay and epileptic encephalopathy.

Journal: Frontiers in pediatrics

Published: July 24, 2023

Effect of the Mendelsohn maneuver and swallowing training in patients with senile vascular dementia complicated with dysphagia.

Effect of the Mendelsohn maneuver and swallowing training in patients with senile vascular dementia complicated with dysphagia.

Journal: The Journal of international medical research

Published: May 15, 2021

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model.

Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model.

Journal: Frontiers in pharmacology

Published: October 18, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026